pFRT-TODestFLAGHA_RBPMS2_HindIII
(Plasmid
#65666)
-
PurposeFLAG-HA expression vector with RBPMS2 carrying mutation to introduce HindIII site
-
Depositing Lab
-
Publication
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 65666 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepcDNA5/FRT/TO
-
Backbone manufacturerLife Technologies, Modified by Tuschl lab
- Backbone size w/o insert (bp) 5372
-
Modifications to backboneintroduced HindIII site (ultimate goal to replace FLAG-HA tag with MYC tag)
-
Vector typeMammalian Expression
-
Selectable markersHygromycin, Blasticidin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)Top10
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert nameRBPMS2
-
SpeciesH. sapiens (human)
-
Mutationintroduced HindIII site (final goal to exchange FLAG-HA tag with MYC tag)
-
GenBank IDNM_194272.1
-
Entrez GeneRBPMS2
- Promoter CMV, 2x Tet
-
Tag
/ Fusion Protein
- FLAG HA (N terminal on backbone)
Cloning Information
- Cloning method Gateway Cloning
- 5′ sequencing primer CMV Forward
- 3′ sequencing primer BGH Reverse (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pFRT-TODestFLAGHA_RBPMS2_HindIII was a gift from Thomas Tuschl (Addgene plasmid # 65666 ; http://n2t.net/addgene:65666 ; RRID:Addgene_65666) -
For your References section:
Structural basis underlying CAC RNA recognition by the RRM domain of dimeric RNA-binding protein RBPMS. Teplova M, Farazi TA, Tuschl T, Patel DJ. Q Rev Biophys. 2015 Sep 8:1-11. 10.1017/S0033583515000207 PubMed 26347403